Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Japara.
RELATED STOCKHEAD STORIES
Health & Biotech
Who got what in the healthcare budget, and which ASX stocks could benefit
Health & Biotech
ASX Health Stocks: Noxopharm gets initial nod for patent, Rhythm tops 11pc on imminent market launch
Health & Biotech
ScoPo’s Powerplays: Recent price swings uncovered hidden gems and buying opportunities in healthcare
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
News
Closing Bell: ASX 200 continues to soar as Japara set to agree to takeover deal
News
ASX Small Cap Lunch Wrap: Who’s got something to cheer about this morning?
News
10 at 10: These ASX stocks have made a sudden ascent this morning
Health & Biotech
Here are the ASX aged care stocks that rose after the $17bn budget windfall
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
News
Last Orders: Despite losing week, best month in six for small caps
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who made $100,000,000,000 last quarter?
Health & Biotech
Japara shares up 23pc on non-binding $278 million takeover offer
News
10 at 10: Investors are liking the smell of these ASX stocks this morning
Health & Biotech
These 7 ASX aged care plays could gain from the Morrison’s government’s $452m boost
Health & Biotech
Check Up: Rhythm leads ASX health stocks on progress on replacement for poo tests
News
